Scientific Program

DAY 1, Thursday - 25th March 2021
Session 1 - Acute Leukemia/MDSChairpersons: Mahmoud Marashi & Amar Lal
16:00 - 16:20Novel Immunotherapies in ALL, What is their Role and How to Manage ToxicitiesRoberto Foà
16:20 - 16:40ICUS /CHIPDavid Steensma
16:40 - 17:00Ph Positive and Ph like ALLRoberto Foà
17:00 - 17:20How I treat MDS in 2021David Steensma
17:20 - 17:30Networking Break
Session 2 - MPNsChairpersons: Asma Sultan Alolama & Shahrukh Hashmi
17:30 - 17:50Diagnostic Workup of MPNAyalew Tefferi
17:50 - 18:10Current Treatment Approach in ET, PV and MFAyalew Tefferi
18:10 - 18:30How to Choose the Right TKI in CMLAyalew Tefferi
18:30 - 19:00Q&A – Meet the ExpertsAmar Lal, Asma Sultan Alolama,
Ayalew Tefferi, Mahmoud Marashi,
Roberto Foà & Sharukh Hashmi
Industry Symposium
19:00 - 19:25Sustained Remission in Patients with ITP(after Romiplostim Tapering and
Discontinuation) - Symposium by Amgen
Amar Lal
19:30 - 20:15Evolving Landscape and emerging FLT3 targeted therapies in AML - Symposium by AstellasChairperson: Asma Sultan Alolama
Speaker: Naval G. Daver

DAY 2, Friday - 26th March 2021
Nursing Workshop – Session 1Chairperson: Khaled Al QawasmehIndustry Symposium
9:00 - 9:25Management of hemophilia B patients with inhibitors (Case Presentation)Khaled Al Habaybia
9:25 - 9:50Biosimilar in Hematology Mahmoud Hasan9:30 - 9:55Sarclisa in achieving greater outcomes for more patients - Symposium by Sanofi GenzymeHani Osman
9:50 - 10:15Effect of Serum albumin on survival rate among newly diagnosed patients with multiple myeloma Nezar Ahmed Salim10:00 - 11:00Industry Symposium by Novartis:
Management of SCD and Dubai Hospital Experience

Identifying Uncontrolled Polycythemia Vera Patients
Husni Al Hateeti
Hassan Al Yassen
Khalid Al Hashmi
10:15 - 10:40Management of CRS in acute refractory ALL patients Khaled Al Qawasmeh
10:40 - 10:45Q&A and Panel DiscussionAll Faculty
10:45 - 10:55Networking Break
Nursing Workshop – Session 2Chairperson: Khaled Al QawasmehIndustry SymposiumSpeaker
10:55 - 11:15Allogenic Bone marrow transplantationHaytham Dana
11:15 - 11:35American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adultsMahmoud Hasan11:05 - 11:30AML Today: New Horizon in Elderly Management - Symposium by AbbvieMahmoud Marashi
11:35 - 12:00New guideline for pain management in sickle cell disease (August 2020)Khaled Al Qawasmeh11:30 - 12:15Role of IXAZOMIB in managing patients with R/R multiple myeloma – Symposium by TakedaAmar Lal
12:00 - 12:10Q&A and Panel DiscussionAll Faculty
12:10 - 16:00Friday Prayer and Networking Break
Session 3 - Plasma Cell DyscrasiaChairpersons: Arif Alam & Shabeeha Rana
16:00 - 16:20Is Minimal Residual Disease Testing Ready to be use in Clinical Practice?Jesús San Miguel
16:20 - 16:40Diagnosis and Management of AL Amyloidosis in 2021Joseph Mikhael
16:40 - 17:00How I Treat Myeloma in Young and Elderly/FrailJesús San Miguel
17:00 - 17:20How I Diagnose and Treat Waldenstrӧm Macroglobulinemia Joseph Mikhael
Session 4 - Best of ASHChairperson: Hasan Al Yaseen
17:20 - 18:05Best of ASHRanjana Advani
18:05 - 19:00Q&A – Meet the ExpertsArif Alam, Hasan Al Yaseen,
Joseph Mikhael, Ranjana Advani
& Shabeeha Rana
Industry Symposium
19:00 - 19:25Redefining CLL Management in 2021 – Symposium by JanssenChair : Asma Sultan Al Olama
Speaker: Paolo Ghia
19:30 - 19:55Management of Hemophilia with Inhibitors ; Adult Experience from Tawam – Symposium by TakedaSabir Hussain
20:00 - 20:25Sharing ASH 2020 congress updates in managing Newly diagnosed MM Patient – Symposium by JanssenChairperson: Mahmoud Marashi
Speaker: Maria Victoria Mateos

Day 3, Saturday – 27th March 2021
Session 5 - Benign Hematology : Hemostasis & ThrombosisChairpersons: Muhammad Faisal Khanani & Amna Al Mehairi
16:00 - 16:20VWD; Case Based Approach in Diagnosis and ManagementAlice Ma
16:20 - 16:40How I Treat HIT; Role of DOACs and High Dose IVIG Theodore Warkentin
16:40 - 17:00Coagulation Factor Replacement in Hemophilia; What is their Place in the Era of Novel TherapiesAlice Ma
17:00 - 17:20Role of Shock Liver in the Pathogenesis of Ischemic Limb Injuries in Critically ill Patients in DICTheodore Warkentin
17:20 - 17:30Networking Break
Session 6 - Benign Hematology : OthersChairpersons: Hani Osman & Salam Al Kindi
17:30 - 17:50How to approach neutropenia in the outpatient setting Neal Young
17:50 - 18:10Challenging Cases in Bone Marrow FailureNeal Young
18:10 -18:30Sickle cell disease: Emerging disease-modifying therapiesMiguel Abboud
18:30 -19:00Q&A – Meet the ExpertsAlice Ma, Amna Al Mehairi, Hani
Osman, Muhammad Faisal
Khanani, Miguel Abboud, Neal Young & Theodore Warkentin
Industry Symposium
19:00 - 19:25Check Point Inhibitor’s in Hodgkin LymphomaPier Luigi Zinzani
Day 4, Sunday – 28th March 2021
Session 7 - Lymphoproliferative Neoplasm IChairpersons: Asma Sultan Alolama & Faraz Khan
16:00 - 16:20Update in Aggressive Lymphoma; Is it Time to Incorporate New Agents?Thomas Witzig
16:20 - 16:40How I Treat Primary CNS Lymphoma in 2021Jeremy Abramson
16:40 - 17:00Follicular Lymphoma; Have We Made Progress?Thomas Witzig
17:00 - 17:20Management of High Risk Hodgkin Lymphoma; Beyond ABVDRanjana Advani
17:20 - 17:30Networking Break
Session 8 - Lymphoproliferative Neoplasm IIChairperson: Riad El Fakih
17:30 - 17:50Car T Cell therapyJeremy Abramson
17:50 - 18:10Double Hit LymphomaRanjana Advani
18:10 - 18:30How I treat CLLJeremy Abramson
18:30 - 19:15Q&A – Meet the ExpertsAsma Sultan Alolama, Jeremy
Abramson, Ranjana Advani, Riad
El Fakih & Thomas Witzig
19:15 - 19:25Closing Remarks